MichaelJosephDattoliMD

Radiation Oncology • Sarasota, FL

Urologic Cancer

Physician-in-Chief, Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, Florida

Join to view full profile

Dr. Dattoli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dattoli's full profile

Already have an account?

Office
2803 Fruitville Rd
Sarasota, FL 34237
Phone+1 941-957-4926

Fax+1 941-957-0038
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 1989 - 1990
NYU Grossman School of MedicineResidency, Radiation Oncology, 1986 - 1989
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 1985 - 1986
Icahn School of Medicine at Mount SinaiClass of 1985

Certifications & Licensure

CA State Medical License 1990 - 2026
FL State Medical License 1990 - 2025
NY State Medical License 1990 - 2022
GA State Medical License 1990 - 2003
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Member, Directors, Prostate Cancer Task Force, Tallahassee Consultant, Washington Oncology Roundtable Advisory Committee
Leading Physicians of the World and Top Brachytherapist 2010-present, Castle-Connolly 2008-present, Patient Compassionate Award 2009-present

Clinical Trials

Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis Start of enrollment: 2005 Nov 01
Completed

Publications & Presentations

PubMed

3 citations
Replacing LNT: The Integrated LNT-Hormesis Model.
Cara Y Kaminski, Michael J. Dattoli, Joseph M Kaminski> ;Dose-Response. 2020 Apr 15
27 citations
Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy
Michael J. Dattoli, Kent E. Wallner, Lawrence D. True, David Bostwick, Jennifer Cash, Richard Sorace> ;Journal of Oncology. 2010 Aug 18
15 citations
Prostatic Acid Phosphatase Adversely Affects Cause-Specific Survival in Patients with Intermediate to High-Risk Prostate Cancer Treated with Brachytherapy
L. Christine Fang, Michael Dattoli, Al V. Taira, Lawrence D. True, Richard Sorace, Kent E. Wallner> ;Urology. 2008 Jan 1
52 citations
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features
Michael J. Dattoli, Kent E. Wallner, Lawrence D. True, Jennifer Cash, Richard Sorace> ;Cancer. 2007 Aug 1
47 citations
Reviving the acid phosphatase test for prostate cancer.
Al V. Taira, Gregory S. Merrick, Kent E. Wallner, Michael J. Dattoli> ;Oncology. 2007 Jul 1
9 citations
Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
Michael J. Dattoli, Kent E. Wallner, Lawrence D. True, Jennifer Cash, Richard Sorace> ;Urology. 2007 Feb 1
39 citations
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid...
Michael Dattoli, Kent Wallner, Lawrence True, Jennifer Cash, Richard Sorace> ;Cancer. 2003 Feb 15
38 citations
Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma.
Michael J. Dattoli, Kent E. Wallner, Lawrence D. True, Richard Sorace, John M. Koval, Jennifer Cash, Rudolph Acosta, Mohendra Biswas, Brent Sullivan, Emilio Lastarria,...> ;International Journal of Radiation Oncology, Biology, Physics. 1999 Nov 1
22 citations
A simple method to stabilize the prostate during transperineal prostate brachytherapy
Michael J. Dattoli, Kent Waller> ;International Journal of Radiation Oncology, Biology, Physics. 1997 May 1
88 citations
Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection.
Kent Wallner, Henry J. Lee, Stuart Wasserman, Michael J. Dattoli> ;International Journal of Radiation Oncology, Biology, Physics. 1997 Feb 1
129 citations
103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma
Michael J. Dattoli, Kent E. Wallner, Richard Sorace, John M. Koval, Jennifer Cash, Rudolph Acosta, Charles Brown, James Etheridge, Richard Brunelle, Novelle Kirwan, Se...> ;International Journal of Radiation Oncology, Biology, Physics. 1996 Jul 15
66 citations
Radiation therapy for intracranial germinoma: the case for limited volume treatment.
Michael J. Dattoli, Joseph Newall> ;International Journal of Radiation Oncology, Biology, Physics. 1990 Aug 1
46 citations
Analysis of multiple prognostic factors in patients with stage IB cervical cancer: age as a major determinant
Michael J. Dattoli, Herbert F. Gretz, Uziel Beller, Irving A. Lerch, Rita I. Demopoulos, E.Mark Beckman, Peter R. Fried> ;International Journal of Radiation Oncology, Biology, Physics. 1989 Jul 1
Management of patients receiving transperineal palladium-103 prostate implants.
Cash, J. C., Dattoli, M. J.> ;Oncol Nurs Forum. 1997 Sep
Join now to see all

Journal Articles

Prostate biopsies using both gray scale and 3D color flow power Doppler ultrasound (3DCFPDU). ASCO-GU, 14100 February 2015
Dattoli,M., Sorace,R., Bostwick, D, JCO, 2/15/2015

Books/Book Chapters